A thorough QTc study of omadacycline to evaluate cardiac repolarisation in healthy volunteers

Trial Profile

A thorough QTc study of omadacycline to evaluate cardiac repolarisation in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2016

At a glance

  • Drugs Omadacycline (Primary) ; Moxifloxacin
  • Indications Community-acquired pneumonia; Nosocomial infections; Skin and soft tissue infections; Urinary tract infections
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Apr 2016 New trial record
    • 12 Apr 2016 Results presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
    • 11 Apr 2016 Results published in the Paratek Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top